SciSparc Ltd. - Ordinary Shares (SPRC)
4.2800
-1.8100 (-29.72%)
NASDAQ · Last Trade: Sep 27th, 11:08 PM EDT
Detailed Quote
Previous Close | 6.090 |
---|---|
Open | 5.280 |
Bid | 4.300 |
Ask | 4.400 |
Day's Range | 4.260 - 5.470 |
52 Week Range | 1.750 - 37.59 |
Volume | 1,475,016 |
Market Cap | 621.24M |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 11,859,362 |
Chart
About SciSparc Ltd. - Ordinary Shares (SPRC)
SciSparc Ltd. is a biotechnology company focused on the development and commercialization of innovative treatments for various medical conditions, particularly those related to the central nervous system. The company is engaged in advancing therapies that aim to address significant unmet needs, utilizing its proprietary platform to explore and enhance the effectiveness of cannabinoid-based treatments. Through its research and development efforts, SciSparc aims to create novel solutions that enhance patient outcomes and improve quality of life in underserved therapeutic areas. Read More
News & Press Releases
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · September 26, 2025
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
Via Benzinga · September 26, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · September 26, 2025
SciSparc Stock Soared 61% Today – Here’s An Important Updatestocktwits.com
Via Stocktwits · September 25, 2025
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
Via Benzinga · September 26, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · September 25, 2025
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Thursday. The Dow traded down 0.64% to 45,824.16 while the NASDAQ fell 1.19% to 22,229.54. The S&P 500 also fell, dropping, 1% to 6,571.28.
Via Benzinga · September 25, 2025
SciSparc Ltd. (NASDAQ: SPRC) stock is surging on Thursday, with a session volume of 58.21 million compared to the average volume of 2.49 million as per data from Benzinga Pro.
Via Benzinga · September 25, 2025
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · September 25, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.
Via Chartmill · September 25, 2025
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday. Following the market opening Thursday, the Dow traded down 0.50% to 45,889.75 while the NASDAQ fell 1.38% to 22,187.39. The S&P 500 also fell, dropping, 0.94% to 6,575.35.
Via Benzinga · September 25, 2025
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · September 25, 2025
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that the board of directors resolved to initiate the launch of an innovative initiative to advance 3D protein modeling using quantum computing technology (the “Initiative”). This new program aims to transform drug discovery by potentially achieving unprecedented accuracy in predicting protein structures and interactions with their ligands, potentially paving the way for breakthroughs in structural biology and personalized medicine.
By SciSparc Ltd · Via GlobeNewswire · September 25, 2025
Via Benzinga · September 18, 2025
Via Benzinga · September 18, 2025
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · September 17, 2025
Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, announced a distribution agreement with AlaBev, one of the Southeast’s premier beverage distributors. The agreement will bring Synergy’s FOCUSfactor® Focus + Energy functional beverages and brain-health energy shots to more than 5,000 grocery, convenience, and specialty retail outlets across Alabama.
Via AB Newswire · September 17, 2025
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!
Via Chartmill · September 17, 2025
Via Benzinga · September 17, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · September 17, 2025
Via Benzinga · September 17, 2025
SciSparc shares are trading sharply higher Wednesday morning. AutoMax Motors filed a motion with the Jerusalem District Court in connection with its merger with the company.
Via Benzinga · September 17, 2025
Via Benzinga · September 17, 2025